Pfizer buys anti-infective specialists Vicuron
June 17, 2005Sales and Marketing
Pfizer has paid almost $2 billion for a US biopharmaceutical company with two promising anti-infective drugs.The acquisition of Vicuron Pharmaceuticals …
AZ fined E60 million by European Commission
June 16, 2005Sales and Marketing
AstraZeneca has been fined E60 million by the European Commission for illegally trying to extend the patent on its ulcer …
Bristol-Myers Squibb to limit direct to consumer advertising
June 15, 2005Medical Communications
Bristol-Myers Squibb has pledged to observe a stricter code of conduct in the promotion of its products to the public …
Older painkillers linked to heart attack risk
June 14, 2005Sales and Marketing
Two widely used painkillers ibuprofen and naproxen have been linked to increased rates of heart attacks in patients, a new …
BMS pays out $89 million in court settlement
June 14, 2005Sales and Marketing
Bristol-Myers Squibb has reached a deal to pay $89 million to settle four lawsuits related to inflated inventories and other …
Hepatitis B market to double by 2010
June 14, 2005Sales and Marketing
The hepatitis B market will double in size by 2010 and hit sales of $1 billion, according to analysts Datamonitor. …
The devil is in the detail
June 10, 2005Practice based commissioning looks set to have a major impact on how pharma companies organise their salesforces and promote and …
Does practice make perfect targeting?
June 3, 2005Sales and Marketing
Since the advent of brick sales information, numerous analytical techniques have become available to help identify the most valuable customers …
GSK sets up new R&D centre
June 1, 2005Research and Development
GlaxoSmithKline has set up its eighth R&D Centre of Excellence which will focus on building partnerships with biotech firms, academia …
ABPI welcomes new report on animal research
June 1, 2005Sales and Marketing
The ABPI has welcomed a new report on the ethics of animal research, agreeing the industry must challenge the need …
Industry encouraged to invest more in pharmacy partnerships
May 27, 2005Research and Development
Pharmaceutical companies should increase their investment in community pharmacists, according to a leading pharmacy spokesperson.Michael Holden, NHS development manager at …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
